Analysts at Jefferies Kept the Same their Past ‘”Hold”’ rating on Shares INC Research Holdings (NASDAQ:INCR), Set a $62.5 Target

September 17, 2017 - By Darrin Black

 Analysts at Jefferies Kept the Same their Past ‘

Investors sentiment decreased to 1.2 in 2016 Q4. Its down 0.84, from 2.04 in 2016Q3. It turned negative, as 21 investors sold INC Research Holdings Inc shares while 79 reduced holdings. 39 funds opened positions while 81 raised stakes. 51.39 million shares or 0.02% more from 51.38 million shares in 2016Q3 were reported.

Parametric Portfolio Ltd Liability Com has invested 0.01% in INC Research Holdings Inc (NASDAQ:INCR). Vanguard Group Inc Inc reported 5.66M shares. Moreover, Sawgrass Asset Ltd Limited Liability Company has 0.05% invested in INC Research Holdings Inc (NASDAQ:INCR). Balyasny Asset Ltd Limited Liability Company reported 54,354 shares. Wellington Mgmt Group Limited Liability Partnership holds 0% or 70,202 shares. Fmr Ltd Liability reported 258,890 shares. Samlyn Llc invested 0.62% in INC Research Holdings Inc (NASDAQ:INCR). Ftb Advsrs reported 0% in INC Research Holdings Inc (NASDAQ:INCR). Hood River Cap Ltd has invested 0% in INC Research Holdings Inc (NASDAQ:INCR). Tudor Corporation Et Al holds 0.37% or 273,814 shares in its portfolio. Brinker Capital stated it has 0.01% of its portfolio in INC Research Holdings Inc (NASDAQ:INCR). Usca Ria Lc reported 8,650 shares. Boston Advsrs Ltd Limited Liability Company has invested 0.29% in INC Research Holdings Inc (NASDAQ:INCR). Van Eck Assocs accumulated 646 shares or 0% of the stock. Bancorp Of Mellon Corp reported 0% of its portfolio in INC Research Holdings Inc (NASDAQ:INCR).

INC Research Holdings (NASDAQ:INCR) Rating Reaffirmed

In a note revealed to investors on Monday, 11 September, The “Hold” rating of INC Research Holdings (NASDAQ:INCR) shares was restate by Jefferies, who now has a $62.5 price target on the stock. Jefferies’s price target means a possible upside of 13.95 % from the last price of the company.

Investors sentiment decreased to 1.2 in 2016 Q4. Its down 0.84, from 2.04 in 2016Q3. It turned negative, as 21 investors sold INC Research Holdings Inc shares while 79 reduced holdings. 39 funds opened positions while 81 raised stakes. 51.39 million shares or 0.02% more from 51.38 million shares in 2016Q3 were reported.

Parametric Portfolio Ltd Liability Com has invested 0.01% in INC Research Holdings Inc (NASDAQ:INCR). Vanguard Group Inc Inc reported 5.66M shares. Moreover, Sawgrass Asset Ltd Limited Liability Company has 0.05% invested in INC Research Holdings Inc (NASDAQ:INCR). Balyasny Asset Ltd Limited Liability Company reported 54,354 shares. Wellington Mgmt Group Limited Liability Partnership holds 0% or 70,202 shares. Fmr Ltd Liability reported 258,890 shares. Samlyn Llc invested 0.62% in INC Research Holdings Inc (NASDAQ:INCR). Ftb Advsrs reported 0% in INC Research Holdings Inc (NASDAQ:INCR). Hood River Cap Ltd has invested 0% in INC Research Holdings Inc (NASDAQ:INCR). Tudor Corporation Et Al holds 0.37% or 273,814 shares in its portfolio. Brinker Capital stated it has 0.01% of its portfolio in INC Research Holdings Inc (NASDAQ:INCR). Usca Ria Lc reported 8,650 shares. Boston Advsrs Ltd Limited Liability Company has invested 0.29% in INC Research Holdings Inc (NASDAQ:INCR). Van Eck Assocs accumulated 646 shares or 0% of the stock. Bancorp Of Mellon Corp reported 0% of its portfolio in INC Research Holdings Inc (NASDAQ:INCR).

INC Research Holdings Inc (NASDAQ:INCR) Ratings Coverage

Among 11 analysts covering INC Research Holdings (NASDAQ:INCR), 7 have Buy rating, 0 Sell and 4 Hold. Therefore 64% are positive. INC Research Holdings has $6800 highest and $47 lowest target. $57.35’s average target is 4.56% above currents $54.85 stock price. INC Research Holdings had 21 analyst reports since August 14, 2015 according to SRatingsIntel. The company was initiated on Thursday, November 19 by Suntrust Robinson. On Friday, August 14 the stock rating was reinitiated by Credit Suisse with “Outperform”. Jefferies maintained it with “Hold” rating and $62.5 target in Monday, September 11 report. The stock of INC Research Holdings Inc (NASDAQ:INCR) earned “Outperform” rating by Robert W. Baird on Thursday, May 11. The stock has “Buy” rating by SunTrust on Thursday, November 19. The company was upgraded on Wednesday, May 31 by SunTrust. The rating was upgraded by Jefferies on Tuesday, September 1 to “Buy”. The rating was maintained by Goldman Sachs with “Buy” on Friday, August 12. The firm has “Equal-Weight” rating by First Analysis given on Tuesday, December 20. Jefferies maintained the stock with “Hold” rating in Thursday, July 27 report.

The stock increased 0.73% or $0.4 on September 15, reaching $54.85. About 1.62M shares traded or 89.27% up from the average. INC Research Holdings Inc (NASDAQ:INCR) has risen 27.42% since September 17, 2016 and is uptrending. It has outperformed by 10.72% the S&P500.

Investors wait INC Research Holdings Inc (NASDAQ:INCR) to report on October, 30. its quarterly earnings Wall Street analysts expect $0.55 earnings per share, down $0.04 or 6.78 % from last year’s $0.59 same quarter earnings. This translates into $29.78 million profit for INCR giving the stock a 24.93 P/E. This is assuming the current $0.55 EPS is accurate. INC Research Holdings Inc’s Wall Street analysts see -3.51 % negative EPS growth, taking into account the $0.57 EPS reproted in the previous quarter,

INC Research Holdings, Inc. is a global contract research organization . The company has market cap of $2.97 billion. The Firm focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. It has a 33.86 P/E ratio. The Firm operates through two divisions: Clinical Development Services and Phase I Services.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: